Disability Benefits for Melanoma

How SSA Evaluates Melanoma Under Listing 13.29

SSA evaluates malignant melanoma, an aggressive skin cancer that can spread widely, under Blue Book listing 13.29. The listing is met when the melanoma is:

• Recurrent — the melanoma has returned after surgery or other treatment, beyond a purely local recurrence at the original site.
• Metastatic to the regional lymph nodes — the cancer has spread to the lymph nodes near the original tumor.
• Metastatic beyond the regional lymph nodes — the cancer has spread to distant sites such as the skin elsewhere on the body, the lungs, liver, brain, or bones.

Melanoma that has spread to distant sites is on SSA's Compassionate Allowances list, so those claims are flagged for expedited processing and can be approved in weeks.

Early-Stage Melanoma

A thin, early melanoma that is completely removed with clear margins usually does not meet listing 13.29, and many people are cured by surgery alone. The listing focuses on melanoma that has spread or returned, because that is when the disease becomes life-threatening and treatment becomes intensive. If your melanoma is advanced, modern treatments such as immunotherapy (checkpoint inhibitors) and targeted therapy have improved survival, but they cause significant side effects — fatigue, inflammation of the joints, colon, thyroid, or other organs, and skin reactions — that SSA can weigh when assessing your ability to work.

Medical Evidence SSA Needs for a Melanoma Claim

The evidence that decides most melanoma claims documents the depth of the original tumor and any spread:

• Biopsy and pathology reports confirming melanoma and giving the Breslow depth and other features that describe how aggressive it is.
• Sentinel lymph node biopsy results, which show whether the cancer has reached the regional lymph nodes.
• Imaging — CT, PET, and brain MRI documenting spread to distant sites, which is critical for the listing and for Compassionate Allowances.
• Operative reports from wide excision and any lymph node surgery.
• Treatment records — immunotherapy and targeted therapy, along with documented immune-related side effects affecting the joints, bowel, thyroid, liver, or skin.

If your records describe the melanoma as recurrent or metastatic, make sure that language and the supporting scans reach SSA, because those facts can meet the listing on their own.

Qualifying Without Meeting the Melanoma Listing

If your melanoma was caught early and removed, you may still qualify through a residual functional capacity (RFC) assessment if treatment or complications limit you. For advanced melanoma treated with immunotherapy, the side effects often drive the RFC case: fatigue that requires rest, immune-related inflammation of the joints that limits movement, colitis that demands frequent restroom access, and thyroid or adrenal problems that cause weakness and low energy. Brain metastases and their treatment can cause seizures, headaches, and cognitive changes.

SSA combines these limitations into an RFC and compares it to your past work. If you cannot return to your old job, the medical-vocational grid rules apply, based on your age, education, and work history. Claimants age 50 and older limited to sedentary work, or 55 and older limited to light work, are often found disabled under the grids. Frequent treatment visits and side-effect flares that cause two or more absences a month can rule out full-time work on their own.

Tips for a Stronger Melanoma Claim

These steps strengthen melanoma claims:

• Apply right away if your melanoma has spread. Metastatic melanoma is a Compassionate Allowances condition, and flagging the spread clearly can lead to approval in weeks.
• Submit the pathology report and staging scans yourself so the fast-track system identifies your claim.
• Point to any recurrence or metastasis in your records, since that language meets listing 13.29.
• Report immunotherapy side effects at every visit — joint pain, colitis, and thyroid problems all matter to an RFC case.
• Keep every scan and follow-up appointment, because they document the disease and keep your file current.